On the road to ending the COVID-19 pandemic: Are we there yet?Virology. 2021 05; 557:70-85.V
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged into the human population in late 2019 and caused the global COVID-19 pandemic. SARS-CoV-2 has spread to more than 215 countries and infected many millions of people. Despite the introduction of numerous governmental and public health measures to control disease spread, infections continue at an unabated pace, suggesting that effective vaccines and antiviral drugs will be required to curtail disease, end the pandemic, and restore societal norms. Here, we review the current developments in antibody and vaccine countermeasures to limit or prevent disease.
Links
MeSH
AnimalsAntibodies, ViralCOVID-19COVID-19 VaccinesClinical Trials as TopicDisease Models, AnimalGenetic VectorsHumansImmunity, InnateImmunization, PassiveImmunogenicity, VaccinePandemicsPatient SafetySARS-CoV-2Vaccines, AttenuatedVaccines, DNAVaccines, SubunitVaccines, Virus-Like ParticleCOVID-19 Serotherapy
Pub Type(s)
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Language
eng
PubMed ID
33676349
Citation
Case, James Brett, et al. "On the Road to Ending the COVID-19 Pandemic: Are We There Yet?" Virology, vol. 557, 2021, pp. 70-85.
Case JB, Winkler ES, Errico JM, et al. On the road to ending the COVID-19 pandemic: Are we there yet? Virology. 2021;557:70-85.
Case, J. B., Winkler, E. S., Errico, J. M., & Diamond, M. S. (2021). On the road to ending the COVID-19 pandemic: Are we there yet? Virology, 557, 70-85. https://doi.org/10.1016/j.virol.2021.02.003
Case JB, et al. On the Road to Ending the COVID-19 Pandemic: Are We There Yet. Virology. 2021;557:70-85. PubMed PMID: 33676349.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - On the road to ending the COVID-19 pandemic: Are we there yet?
AU - Case,James Brett,
AU - Winkler,Emma S,
AU - Errico,John M,
AU - Diamond,Michael S,
Y1 - 2021/02/26/
PY - 2020/12/23/received
PY - 2021/02/12/revised
PY - 2021/02/12/accepted
PY - 2021/3/7/pubmed
PY - 2021/3/31/medline
PY - 2021/3/6/entrez
KW - Antibody
KW - COVID-19
KW - Immunity
KW - Pathogenesis
KW - Protection
KW - SARS-CoV-2
KW - Therapy
KW - Vaccines
SP - 70
EP - 85
JF - Virology
JO - Virology
VL - 557
N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged into the human population in late 2019 and caused the global COVID-19 pandemic. SARS-CoV-2 has spread to more than 215 countries and infected many millions of people. Despite the introduction of numerous governmental and public health measures to control disease spread, infections continue at an unabated pace, suggesting that effective vaccines and antiviral drugs will be required to curtail disease, end the pandemic, and restore societal norms. Here, we review the current developments in antibody and vaccine countermeasures to limit or prevent disease.
SN - 1096-0341
UR - https://www.unboundmedicine.com/medline/citation/33676349/On_the_road_to_ending_the_COVID_19_pandemic:_Are_we_there_yet
DB - PRIME
DP - Unbound Medicine
ER -